Results for tag: "Daklinza"

Daklinza (daclatasvir) is a prescription medication used to treat chronic hepatitis C virus (HCV) infection in adults. It is a direct-acting antiviral (DAA) that works by blocking the action of the HCV virus in the body. Daklinza is used in combination with other medications to treat HCV genotypes 1, 2, 3, and 4. It is also used to treat liver and kidney disorders caused by HCV. Daklinza is available in tablet form and is taken once daily with food. Common side effects include headache, fatigue, nausea, and insomnia. Serious side effects include liver problems, allergic reactions, and low blood sugar. The Daklinza market is composed of pharmaceutical companies that manufacture and distribute the drug. Companies in the market include Bristol-Myers Squibb, Merck, Gilead Sciences, AbbVie, and Janssen Pharmaceuticals. Show Less Read more